JPWO2022168968A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022168968A5 JPWO2022168968A5 JP2022579637A JP2022579637A JPWO2022168968A5 JP WO2022168968 A5 JPWO2022168968 A5 JP WO2022168968A5 JP 2022579637 A JP2022579637 A JP 2022579637A JP 2022579637 A JP2022579637 A JP 2022579637A JP WO2022168968 A5 JPWO2022168968 A5 JP WO2022168968A5
- Authority
- JP
- Japan
- Prior art keywords
- peripheral neuropathy
- agent
- preventing
- improving
- improving peripheral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000033808 peripheral neuropathy Diseases 0.000 claims 8
- 239000003795 chemical substances by application Substances 0.000 claims 6
- 239000002246 antineoplastic agent Substances 0.000 claims 3
- UNXHWFMMPAWVPI-QWWZWVQMSA-N D-threitol Chemical compound OC[C@@H](O)[C@H](O)CO UNXHWFMMPAWVPI-QWWZWVQMSA-N 0.000 claims 2
- 230000029115 microtubule polymerization Effects 0.000 claims 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical group [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims 2
- 208000032131 Diabetic Neuropathies Diseases 0.000 claims 1
- FBPFZTCFMRRESA-OMMKOOBNSA-N L-altritol Chemical compound OC[C@H](O)[C@H](O)[C@H](O)[C@@H](O)CO FBPFZTCFMRRESA-OMMKOOBNSA-N 0.000 claims 1
- 229940079156 Proteasome inhibitor Drugs 0.000 claims 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 229940041181 antineoplastic drug Drugs 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims 1
- 229910052697 platinum Inorganic materials 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 239000003207 proteasome inhibitor Substances 0.000 claims 1
- 239000003381 stabilizer Substances 0.000 claims 1
- 239000000811 xylitol Substances 0.000 claims 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims 1
- 229960002675 xylitol Drugs 0.000 claims 1
- 235000010447 xylitol Nutrition 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021017510 | 2021-02-05 | ||
| PCT/JP2022/004603 WO2022168968A1 (ja) | 2021-02-05 | 2022-02-07 | 末梢神経障害の予防又は改善剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022168968A1 JPWO2022168968A1 (https=) | 2022-08-11 |
| JPWO2022168968A5 true JPWO2022168968A5 (https=) | 2023-11-01 |
Family
ID=82741199
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022579637A Pending JPWO2022168968A1 (https=) | 2021-02-05 | 2022-02-07 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20240099989A1 (https=) |
| JP (1) | JPWO2022168968A1 (https=) |
| WO (1) | WO2022168968A1 (https=) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60213592T2 (de) * | 2001-05-25 | 2007-08-09 | Warner-Lambert Co. Llc | Flüssige pharmazeutische zusammensetzung |
| US7919107B2 (en) * | 2008-07-28 | 2011-04-05 | Sudzucker Aktiengesellschaft Mannhein/Ochsenfurt | Method for treating hypersensitive teeth |
| IL206739A (en) * | 2010-06-30 | 2016-06-30 | David Segal | An injectable drug containing silitol as an active substance |
| CN105287618A (zh) * | 2015-09-28 | 2016-02-03 | 天津市聚星康华医药科技有限公司 | 一种治疗神经性疼痛的口服药物组合物及其应用 |
| CA3009152C (en) * | 2015-12-25 | 2023-08-15 | Toyama Chemical Co., Ltd. | Tablet comprising 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or salt thereof |
| JP6919119B2 (ja) * | 2017-01-23 | 2021-08-18 | 日新製薬株式会社 | ３位が置換されたγ−アミノ酪酸誘導体を含有する圧縮固形医薬組成物。 |
-
2022
- 2022-02-07 US US18/275,521 patent/US20240099989A1/en active Pending
- 2022-02-07 JP JP2022579637A patent/JPWO2022168968A1/ja active Pending
- 2022-02-07 WO PCT/JP2022/004603 patent/WO2022168968A1/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015083580A5 (https=) | ||
| Ling et al. | A review of currently available fenofibrate and fenofibric acid formulations | |
| CN102438604B (zh) | 高致病性传染性疾病的预防及治疗制剂 | |
| EP4344743A3 (en) | Heterocyclic flavone derivatives, compositions, and methods related thereto | |
| Jampílek et al. | Nanoantimicrobials: Activity, benefits, and weaknesses | |
| Malagola et al. | Acetazolamide-induced cilio-choroidal effusion after cataract surgery: unusual posterior involvement | |
| Ossig et al. | Treatment strategies in early and advanced Parkinson disease | |
| JP2006506378A5 (https=) | ||
| RU2019105953A (ru) | Композиции и связанные с ними способы | |
| JP2020514282A5 (https=) | ||
| JP2017522300A5 (https=) | ||
| JP2019131588A5 (ja) | 抗そう痒剤 | |
| ATE464883T1 (de) | Geschmacksabdeckende formulierung mit einer retardierten wirkstoffformulierung und/oder schnell löslichem cyclodextrin | |
| CN111902417A (zh) | 一种二芳基巨环化合物、药物组合物以及其用途 | |
| ZA202309001B (en) | Abhd6 antagonist | |
| JPWO2022168968A5 (https=) | ||
| JP2020510045A5 (https=) | ||
| Bajpai et al. | Design and in vitro evaluation of compression-coated pulsatile release tablets of losartan potassium | |
| JP2016135782A5 (https=) | ||
| RU2020124373A (ru) | Профилактический агент и/или терапевтический агент для катаракты, медицинский состав для предотвращения и/или лечения катаракты, применение ppar-активатора для тех же целей и глазные капли | |
| JP2020509072A5 (https=) | ||
| JP2008540405A5 (https=) | ||
| ES2590209T3 (es) | Composiciones para el tratamiento de la fatiga asociada al cáncer | |
| JP2013513651A5 (https=) | ||
| WO2018211336A3 (en) | Solid dosage form containing sorafenib tosylate |